| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $583.1M | +22.5% |
| Cost of Revenue | $108.7M | +25.0% |
| Gross Profit | $474.4M | +22.0% |
| R&D Expense | $222.6M | +13.9% |
| SG&A Expense | $137.0M | +1.5% |
| Operating Income | -$254.3M | +14.5% |
| Pre-tax Income | -$189.6M | +30.6% |
| Income Tax | $1.0M | +2.6% |
| Net Income | -$190.7M | +30.5% |
| EPS (Basic) | -$0.98 | +33.3% |
| EPS (Diluted) | -$0.98 | +33.3% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $763.4M | -40.6% |
| Accounts Receivable | $182.6M | +12.5% |
| Current Assets | $1.54B | +2.2% |
| Total Assets | $1.69B | +3.9% |
| Current Liabilities | $440.8M | +15.7% |
| Total Liabilities | $479.0M | +13.2% |
| Stockholders' Equity | $1.21B | +0.6% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.9M | +87.2% |
| Capital Expenditures | $697K | +176.6% |
| Investing Cash Flow | -$535.2M | -5847.7% |
| Financing Cash Flow | $23.3M | +6.0% |
| Free Cash Flow | -$11.5M | +86.4% |